Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-312-3 | CAS number: 53880-05-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Respiratory sensitisation
Administrative data
- Endpoint:
- respiratory sensitisation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1995-04-03 - 1995-05-04
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: exposure criteria of OECD 403 and EC Guideline 892/69/EEC (1992) were fullfilled
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: exposure criteria of OECD 403 and EC Guideline 892/69/EEC (1992) were fullfilled
- GLP compliance:
- yes
Test material
- Reference substance name:
- 3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomers
- EC Number:
- 500-125-5
- EC Name:
- 3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate, oligomers
- Cas Number:
- 53880-05-0
- Molecular formula:
- residual C12H18N2O2, otherwise C36H54N6O6 (trimer) and higher species
- IUPAC Name:
- 3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate homopolymer
- Reference substance name:
- 3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate homopolymer, isocyanurate type
- EC Number:
- 931-312-3
- Cas Number:
- 53880-05-0
- Molecular formula:
- residual C12H18N2O2, otherwise C36H54N6O6 (trimer) and higher species
- IUPAC Name:
- 3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate homopolymer, isocyanurate type
- Details on test material:
- Test itemDistribution of molecular weights: IPDI-monomer: ca. 0.3%; IPDI-Trimer: 50-60%; IPDI-Polymer: 40-50%
Constituent 1
Constituent 2
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS:
- Strain: DHPW (Dunkin-Hartley Pirbright-White) strain from the Charles River [Crl:(HA)BR]
- Sex: female
- Source: Sulzfeld, Germany
- Age: ca. 2 weeks
- Weight at study initiation:
- pre-experimental treatment of animals and animal housing: animals were acclimatized for at least 5 days before use;before start of experiment
health status of each animal was assessed; animals were assigned to exposure gruops at random; room temperature: 22 °C (+/- 2°C);
humidity: appr. 50%; dark/light: 12h/12h (14 watt/m2); air-exchange: appr. 10-fold/h; diet: Altromin 3022 (Altromin GmbH, Lage);
tap-water ad libitum
Test system
- Route of induction exposure:
- other: intradermal or inhalation
- Route of challenge exposure:
- other: nose only inhalation of aerosol
- Vehicle:
- other: intradermal: aceton; inhalation: unchanged (no vehicle)
- Concentration:
- see: "Details on study design"
- No. of animals per dose:
- 8 treated (intradermal and inhalation)
8 vehicle (control - Details on study design:
- STUDY DESIGN:
Groups of eight female guinea-pigs were intradermally induced once per day on days 0, 2, and 4 (injection volume: 50 µl; 5% solution in aceton) and
one additional group of animals was exposed for five consecutive days by inhalation (duration of exposure per day: 3 hrs/day) to 147 mg/m3
IPDI-homopolymer dust (solid aerosol). The aerosolized test item proved to be of adequate respirability (MMAD approximately 2.1 µm, GSD ca. 1.8;
relative mass of particle <= 3 µm approximately 75%). Eight female controls received the vehicle alone (acetone intradermally) under otherwise
identical conditions. During the recovery period (starting on day 21) a IPDI-challenge (mean concentration: 48 mg/m3 air) was performed (challenge duration: 30 min) which was followed (one day after hapten challenge) by an acetylcholine bronchoprovocation challenge (ramped
concentrations).
Following day 28 all guinea pigs were challenged again with the guinea pig serum albumin (GPSA) conjugate of the hapten (mean concentration:
49 mg/m3 air).
During and after challenge exposures immediate-onset respiratory reactions were evaluated by measurement of respiratory rate, tidal volume,
respiratory minute volume, inspiratory and expiratory times, and peak expiratory flow rate. Additional parameters were derived mathematically.
One day thereafter, animals were sacrificed, the lungs, including trachea and lung associated lymph nodes, were examined histopathologically. The weight of the exised lungs was determined. At sacrifice blood was sampled for serological examinations. - Challenge controls:
- Treatment: vehicle
- Positive control substance(s):
- trimellitic anhydride (TMA)
- Negative control substance(s):
- other: vehicle (acetone)
Results and discussion
- Results:
- Following induction, mild skin reactions occured which appeared to be related to the vehicle used (acetone). During or following hapten, ACh or conjungate-challenges, the incidence of immediate-onset respiratory reactions were roughly the same in all groups. No deaths or stereotypic anaphylactic reactions were observed during challenge, and no clinical signs, conclusive changes in body weight or specific abnormalities were observed at necropsy. The histopathological investigations were unobstructive, i.e., there was no evidence of a specific airway eosinophilia, a hallmark of allergic airway hyperresponsiveness. The serological investigations did not reveal merked differences in anti-IPDI-Homopolymer IgG1-antibody titres between the groups.
- Positive control results:
- In previous studies the known human respiratory sensitizer TMA was investigated with the current animal model using roughly the same induction
and challenge protocol. The TMA study demonstrated that the experimental approaches employed provide an adequate basis for a clear assessment of chemicals with a strong potential to cause respiratory hypersensitivity in guinea pigs. Upon challenge with TMA, the most of the guinea pigs
experienced a characteristic "waveform" breathing pattern which had not been observed in IPDI homopolymer challenged guinea pigs. This
stereotypic breathing response has not yet been observed in naive animals and therefore provides a solid basis for the classification of strong
respiratory tract sensitizers. - Negative control results:
- no relevant reactions observed
Any other information on results incl. tables
no further remarks
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of this study the test item IPDI-homopolymer did not induce respiratory sensitization in guinea pigs.
- Executive summary:
A lung sensitization study with IPDI-homopolymer was performed in accordance with the exposure criteria defined in OECD TG 403 using female guinea pigs . A standard approach was used that included three intradermal injections (one per day, 5%, 50 µl in acetone). In order to investigate wether the test substance has any potential to induce specific or non-specific airway hyperreactivity an additional group of female guinea pigs was induced by using a 5 x 3 hours inhalation (147 mg/m3) sensitization protocol followed by inhalation challenge with the hapten, acetylchloline and conjugate by inhalation.
Under the conditions of this study no conclusive immediate-onset responses were observed nor was there any indirect evidence of a lung sensitizing potential, i.e. eosinophilia of airways or production of specific antibody. Therefore, this study does not provide any evidence that IPDI-homopolymer is a respiratory sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.